US Patent Issued to EMERGENT BIODEFENSE OPERATIONS LANSING on Dec. 2 for "Formulations of brincidofovir" (North Carolina Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,131, issued on Dec. 2, was assigned to EMERGENT BIODEFENSE OPERATIONS LANSING LLC (Lansing, Mich.).

"Formulations of brincidofovir" was invented by Mohammed Kabir (Cary, N.C.), Odin Johann Naderer (Chapel Hill, N.C.) and Irma Marisa Grossi (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are formulations comprising brincidofovir. The formulations can be intravenous formulations. The formulations can be used in cases where a subject experiences gastrointestinal issues in response to oral administration of brincidofovir. The formulations can also be used in cases where oral administration of drug is not possible due to underlying ...